Specific features of non-small cell lung cancer in women: A retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997

Journal of Thoracic Oncology

Volumn 2, Issue 6, 2007, Pages 466-474

  Foeglé, Jacinthe ^a   Hédelin, Guy ^a   Lebitasy, Marie Paule ^b   Purohit, Ashok ^b   Velten, Michel ^a   Quoix, Elisabeth ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Gender; Management; Non small cell lung cancer; Sex; Survival; Women

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; MITOMYCIN C; NAVELBINE; VINDESINE;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRANCE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE REGRESSION; NEEDLE BIOPSY; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SEX RATIO; SMOKING; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; TRANSBRONCHIAL BIOPSY; BRONCHOSCOPY; CANCER STAGING; COMPARATIVE STUDY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FRANCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34447136137     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01.JTO.0000275340.39960.25     Document Type: Article

References (83)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Baldini EH, Strauss GM. Women and lung cancer: waiting to exhale. Chest 1997;112:229S-234S.
3. Hill C, Doyon F. Frequency of cancer in France: 2004 update. Bull Cancer 2004;91:9-14.
4. Remontet L, Buemi A, Velten M, et al. Evolution de l'Incidence et de la Mortalité par Cancer en France de 1978 à 2000. Août, France: Institut de Veille Sanitaire, 2003.
5. Levi F, Lucchini F, Negri E, et al. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 2004;110:155-169.
6. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the European Union countries. Eur J Cancer 2004;40:96-125.
7. Wakai K, Ando M, Ozasa K, et al. Updated information in risk factors for lung cancer: findings from the JACC study. J Epidemiol 2005;15:S134-S139.
8. Charloux A, Quoix E, Wolkove N, et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 1997;26:14-23.
9. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991;9:1618-1626.
10. Paesmans M, Sculier J, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J Clin Oncol 1995;13:1221-1230.
11. Institut National de la Statistique et des Études Économiques. Estimation Localisée de Population: 1990-1997. Paris. Available at http://www.insee.fr/fr/ffc/docs_ffc/elp_reg_dep.htm. Accessed unknown month and day, 2005.
12. Foegle J, Hedelin G, Lebitasy MP, et al. Non-small-cell lung cancer in a French department, (1982-1997): management and outcome. Br J Cancer 2005;92:459-466.
13. Estève J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990;9:529-538.
14. Hédelin G. Relsurv 2.5c: A Programme for Relative Survival [technical report]. Strasbourg, France: Faculty of Medecine, Louis Pasteur University, 2003.
15. Binder F. Thèse de Médecine: Epidémiogie des Carcinomes Hépatocellulaires dans le Bas-Rhin: Analyse de l'Ensemble des cas Curvenus dans le Département entre 1990 et 1999. Strasbourg, Bas-Rhin: Université Louis Pasteur, 2003.
16. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001;56:212-217.
17. Lebitasy MP, Hédelin G, Purohit A, et al. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 2001;85:808-815.
18. Hill C. Trends in tobacco smoking and consequences on health in France. Prev Med 1998;27:514-519.
19. United States Public Health Service. The Health Consequences of Smoking for Women. Report of the Surgeon General. Washington, DC: United States Department of Health and Human Services, Office of Smoking and Health, U.S. Government Printing Office, 1980.
20. National Cancer Institute. SEER Incidence and US Mortality Statistics. Available at: http://seer.cancer.gov/csr/1973_1999. Accessed February 1, 2007.
21. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA 2004;291:1763-1768.
22. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
23. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30.
24. Ferguson MK, Skosey C, Hoffmann PC, Golomb HM. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990;8:1402-1407.
25. De Perrot M, Licker M, Bouchardy C, et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2000;119:21-26.
26. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20561 cases. Ann Oncol 2002;13:1087-1093.
27. Koyi H, Hillerdal G, Brandén E. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits. Lung Cancer 2002;36:9-14.
28. De Andrade M, Ebbert JO, Wampfler JA, et al. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer 2004;43:127-134.
29. Wu PF, Lee MJ, Wang MJ, et al. Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan. Eur J Cancer 2003;40:260-266.
30. Schwartz AG. Genetic predisposition to lung cancer. Chest 2004;125:86S-89S.
31. Dai XD, Lin CY, Sun XW, et al. The etiology of lung cancer in nonsmoking females in Harbin, China. Lung Cancer 1996;14:S85-S91.
32. Nyberg F, Agrenius V, Svartengren K, et al. Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 1998;430-436.
33. Wu AH, Yu MC, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988;48:7279-7284.
34. Ko YC, Lee CH, Chen MJ, et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 1997;26:24-31.
35. Kreuzer M, Heinrich J, Kreienbrock L, et al. Risk factors for lung cancer among nonsmoking women. Int J Cancer 2002;100:706-713.
36. Chiang TA, Wu PF, Ko YC. Identification of carcinogens in cooking oil fumes. Environ Res 1999;81:18-22.
37. Wu PF, Chiang TA, Ko YC, Lee H. Genotoxicity of fumes from heated cooking oils produced in Taiwan. Environ Res 1999;80:122-126.
38. Quoix E, Mennecier B. Lung cancer and pollution. Rev Pneumol Clin 2003;59:187-195.
39. Soll-Johanning H, Bach E, Olsen JH, Tuchsen F. Cancer incidence in urban bus drivers and tramway employees: a retrospective cohort study. Occup Environ Med 1998;55:594-598.
40. Caltagirone S, Ranelletti FO, Rinelli A, et al. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small cell lung cancer. Am J Respir Cell Mol Biol 1997;17:51-59.
41. Taioli E, Wynder EL. Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-870.
42. Schabath M, Wu X, Vassilopoulou-Sellin, et al. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004;10:113-123.
43. Ganti A, Sahmoun A, Panwalkar A, et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59-63.
44. Zang EA, Wynder EL. Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer 1992;70:69-76.
45. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993;138:281-293.
46. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993;22:592-599.
47. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31:139-148.
48. Henschke CI, Miettinen OS. Women's susceptibility to tobacco carcinogens. Lung Cancer 2004;43:1-5.
49. Wei Q, Cheng L, Amos C, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-1772.
50. Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999;59:3317-3320.
51. Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-2038.
52. Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-2038.
53. Wang Y, Lee H, Chen S, et al. Analysis of K-ras gene mutation in lung carcinomas: correlation with gender, histological subtypes and clinical outcome. J Cancer Res Clin Oncol 1998;124:517-522.
54. Schoenberg JB, Wilcox HB, Mason TJ, et al. Variation in smoking-related lung cancer risk among new Jersey women. Am J Epidemiol 1989;130:688-695.
55. Alavanja MC, Brownson RC, Boice JD, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992;136:623-632.
56. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung cancer risk associated with cigarette smoking. Int J Cancer 1993;54:44-48.
57. Kreuzer M, Boffetta P, Whitley E, et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000;82:227-233.
58. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-478.
59. Prescott E, Osler M, Hein HO, et al. Gender and smoking-related risk of lung cancer. Epidemiology 1998;9:79-83.
60. Bain C, Feskanich D, Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004;96:826-834.
61. Harley HR. Cancer of the lung in women. Thorax 1976;31:254-264.
62. Blanchon F, Grivaux M, Collon T, et al. Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. Rev Mal Respir 2002;19:727-734.
63. Moore R, Doherty D, Chamberlain R, Khuri F. Sex differences in survival in non-small cell lung cancer patients 1974-1998. Acta Oncol 2004;43:57-64.
64. Quoix E. Specific features of bronchial cancer in women. Rev Pneumol Clin 1999;55:290-295.
65. Xie L, Ugnat AM, Moriss J, et al. Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada. Lung Cancer 2003;42:127-139.
66. Koo LC, HO JH. Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol 1990;19:14-23.
67. Muscat JE, Wynder EL. Lung cancer pathology in smokers, ex-smokers and never smokers. Cancer Lett 1995;88:1-5.
68. Kabat GC, Stellman SD, Wynder EL. Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers. Am J Epidemiol 1995;142:141-148.
69. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol 1999;10:S3-S6.
70. Kubina M, Hedelin G, Charloux A, et al. Do patients with squamous cell carcinoma or adenocarcinoma of the lung have different smoking histories? Rev Mal Respir 1999;16:539-549.
71. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001;31:123-137.
72. Marugame T, Sobue T, Nakayama T, et al. Filter cigarette smoking and lung cancer risk; a hospital-based case-control study in Japan. Br J Cancer 2004;90:646-651.
73. Wynder EL, Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 1994;54:5284-5295.
74. Janssen-Heijnen ML, Nab HW, Van Reek J, et al. Striking changes in smoking behaviour and lung cancer incidence by histological type in South-east Netherlands, 1960-1991. Eur J Cancer 1995;31:949-952.
75. Charloux A, Rossignol M, Purohit A, et al. International differences in epidemiology of lung adenocarcinoma. Lung Cancer 1997;16:133-143.
76. Zélicourt M, Detoutnay B, Comte S, Stockemer V. Epidemiology and costs of lung cancer in France. Bull Cancer 2001;88:753-758.
77. Ouellette D, Desbiens G, Emond C, Beauchamp G. Lung cancer in women compared with men: stage, treatment, and survival. Ann Thorac Surg 1998;66:1140-1144.
78. Robnett T, Machtay M, Vines E, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000;48:89-94.
79. Earle CC, Neumann PJ, Gelber RD, et al. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002;20:1786-1792.
80. Mahmud SM, Reilly M, Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer 2003;41:57-64.
81. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2001. Available at: http://seer.cancer.gov/csr/1975_2001. Accessed April 10, 2007.
82. Moro D, Nagy-Mignotte H, Bolla M, et al. Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in an oncology department. Bull Cancer 1997;84:155-161.
83. Palomares MR, Sayre JW, Shekar KC, et al. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996;78:2119-2126.